Literature DB >> 1316938

Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2.

F Taguchi1, T Ikeda, H Shida.   

Abstract

A cDNA encoding the spike (S) protein of the neurovirulent murine coronavirus JHMV variant cl-2 was isolated and sequenced. Analysis of the cDNA revealed that the S protein consists of 1376 amino acids, as does the S protein of mouse hepatitis virus 4. We inserted the cDNA into the genome of vaccinia virus to obtain a recombinant vaccinia virus (rVV). The S protein expressed in RK13 cells infected by the rVV was shown to be electrophoretically and immunologically indistinguishable from the S protein produced in DBT cells infected with cl-2 virus. RVV infection of rats and mice induced S protein-specific antibody production detectable by immunofluorescence and neutralization. Moreover, the S protein expressed by the rVV induced syncytium formation not only in mouse DBT and L cells, which are susceptible to cl-2 virus infection, but also in rabbit RK13 cells, which are not susceptible to cl-2 virus infection. This result suggests the possibility that RK13 cells have binding sites for the cl-2 virus S protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316938     DOI: 10.1099/0022-1317-73-5-1065

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure.

Authors:  C L Rowe; J O Fleming; M J Nathan; J Y Sgro; A C Palmenberg; S C Baker
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Analysis of the receptor-binding site of murine coronavirus spike protein.

Authors:  H Suzuki; F Taguchi
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

3.  Receptor-induced conformational changes of murine coronavirus spike protein.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.

Authors:  Susan T Hingley; Isabelle Leparc-Goffart; Su-Hun Seo; Jean C Tsai; Susan R Weiss
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.

Authors:  Guiqing Peng; Dawei Sun; Kanagalaghatta R Rajashankar; Zhaohui Qian; Kathryn V Holmes; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

6.  The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.

Authors:  E C Bos; W Luytjes; W J Spaan
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

Authors:  K Saeki; N Ohtsuka; F Taguchi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding.

Authors:  F Taguchi
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein.

Authors:  Evelena Ontiveros; Taeg S Kim; Thomas M Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice.

Authors:  Tanya A Miura; Emily A Travanty; Lauren Oko; Helle Bielefeldt-Ohmann; Susan R Weiss; Nicole Beauchemin; Kathryn V Holmes
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.